According to Biolase
's latest financial reports the company has a price-to-book ratio of 0.00954167.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | -0.0840 | -99.46% |
2023-12-31 | -15.5 | -1733.33% |
2022-12-31 | 0.9500 | -59.94% |
2021-12-31 | 2.37 | -38.97% |
2020-12-31 | 3.89 | -91.57% |
2019-12-31 | 46.1 | 2350.01% |
2018-12-31 | 1.88 | 26.14% |
2017-12-31 | 1.49 | -65.21% |
2016-12-31 | 4.29 | 118.18% |
2015-12-31 | 1.96 | -45.93% |
2014-12-31 | 3.63 | -69.06% |
2013-12-31 | 11.7 | 139.33% |
2012-12-31 | 4.91 | -21.61% |
2011-12-31 | 6.26 | -144.75% |
2010-12-31 | -14.0 | -338.24% |
2009-12-31 | 5.87 | 52.63% |
2008-12-31 | 3.85 | 11.99% |
2007-12-31 | 3.44 | -63.73% |
2006-12-31 | 9.47 | 8.39% |
2005-12-31 | 8.74 | 21.3% |
2004-12-31 | 7.20 | -37.12% |
2003-12-31 | 11.5 | -67.94% |
2002-12-31 | 35.7 |